Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Eyenovia, Inc. (EYEN) since 2018 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Eyenovia, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1682639.
Total stock buying since 2018: $17,206,212.
Total stock sales since 2018: $1,275,000.
Total stock option exercises since 2018: $885,527.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 1,752,939 | $1,218,985 | 0 | $0 | 0 | $0 |
| 2023 | 196,994 | $459,244 | 270,000 | $1,275,000 | 10,000 | $27,200 |
| 2022 | 445,944 | $959,417 | 0 | $0 | 0 | $0 |
| 2021 | 563,446 | $2,266,949 | 0 | $0 | 24,510 | $47,794 |
| 2020 | 1,931,722 | $4,599,186 | 0 | $0 | 26,737 | $52,137 |
| 2019 | 418,886 | $1,197,552 | 0 | $0 | 487,020 | $701,915 |
| 2018 | 653,800 | $6,504,879 | 0 | $0 | 28,965 | $56,481 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-08 | 77,071 | $42,575 | 0 | $0 | 0 | $0 |
| 2024-07 | 1,515,151 | $999,999 | 0 | $0 | 0 | $0 |
| 2024-03 | 160,717 | $176,411 | 0 | $0 | 0 | $0 |
| 2023-12 | 4,890 | $6,650 | 0 | $0 | 0 | $0 |
| 2023-09 | 7,357 | $12,410 | 0 | $0 | 0 | $0 |
| 2023-08 | 75,000 | $141,915 | 0 | $0 | 0 | $0 |
| 2023-05 | 109,747 | $298,269 | 90,000 | $495,000 | 10,000 | $27,200 |
| 2023-04 | 0 | $0 | 140,000 | $640,000 | 0 | $0 |
| 2023-03 | 0 | $0 | 40,000 | $140,000 | 0 | $0 |
| 2022-12 | 31,753 | $48,029 | 0 | $0 | 0 | $0 |
| 2022-08 | 21,361 | $34,447 | 0 | $0 | 0 | $0 |
| 2022-06 | 100,000 | $165,000 | 0 | $0 | 0 | $0 |
| 2022-05 | 142,000 | $296,980 | 0 | $0 | 0 | $0 |
| 2022-04 | 58,800 | $151,492 | 0 | $0 | 0 | $0 |
| 2022-03 | 4,000 | $12,460 | 0 | $0 | 0 | $0 |
| 2022-02 | 88,030 | $251,009 | 0 | $0 | 0 | $0 |
| 2021-12 | 100,000 | $345,000 | 0 | $0 | 0 | $0 |
| 2021-11 | 134,000 | $497,291 | 0 | $0 | 0 | $0 |
| 2021-10 | 150,511 | $598,258 | 0 | $0 | 0 | $0 |
| 2021-09 | 1,500 | $6,600 | 0 | $0 | 0 | $0 |
| 2021-08 | 74,343 | $295,918 | 0 | $0 | 0 | $0 |
| 2021-06 | 6,000 | $32,512 | 0 | $0 | 24,510 | $47,794 |
| 2021-05 | 1,400 | $6,594 | 0 | $0 | 0 | $0 |
| 2021-04 | 60,692 | $292,276 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-08-28 | Rowe Michael M (Chief Executive Officer) | Buy | 27,071 | .52 | 14,076 |
| 2024-08-26 | Rowe Michael M (Chief Executive Officer) | Buy | 50,000 | .57 | 28,499 |
| 2024-07-02 | Grant Stuart M. | Buy | 1,515,151 | .66 | 999,999 |
| 2024-03-28 | Grant Stuart M. | Buy | 100,000 | .98 | 98,000 |
| 2024-03-19 | Grant Stuart M. | Buy | 50,000 | 1.23 | 61,500 |
| 2024-03-08 | Grant Stuart M. | Buy | 10,717 | 1.58 | 16,911 |
| 2023-12-04 | Rowe Michael M (Chief Executive Officer) | Buy | 4,890 | 1.36 | 6,650 |
| 2023-09-29 | Strahlman Ellen R | Buy | 4,820 | 1.68 | 8,097 |
| 2023-09-19 | Rowe Michael M (Chief Executive Officer) | Buy | 1,400 | 1.66 | 2,324 |
| 2023-09-15 | Rowe Michael M (Chief Executive Officer) | Buy | 1,137 | 1.75 | 1,989 |
| 2023-08-17 | Grant Stuart M. | Buy | 30,000 | 1.87 | 56,100 |
| 2023-08-16 | Grant Stuart M. | Buy | 45,000 | 1.91 | 85,815 |
| 2023-05-31 | Gandolfo John P (Chief Financial Officer) | Buy | 2,000 | 2.79 | 5,580 |
| 2023-05-26 | Kern Bren (Chief Operating Officer) | Buy | 2,500 | 2.73 | 6,825 |
| 2023-05-26 | Mather Charles E Iv | Buy | 3,000 | 2.49 | 7,470 |
| 2023-05-25 | Grant Stuart M. | Buy | 88,247 | 2.65 | 233,854 |
| 2023-05-23 | Strahlman Ellen R | Buy | 10,000 | 3.10 | 30,980 |
| 2023-05-15 | Mather Charles E Iv | Buy | 4,000 | 3.39 | 13,560 |
| 2023-05-01 | Rowe Michael M (Chief Executive Officer) | Option Ex | 10,000 | 2.72 | 27,200 |
| 2023-05-01 | Ianchulev Tsontcho | Sale | 90,000 | 5.50 | 495,000 |
| 2023-04-27 | Ianchulev Tsontcho | Sale | 60,000 | 5.00 | 300,000 |
| 2023-04-14 | Ianchulev Tsontcho | Sale | 40,000 | 4.50 | 180,000 |
| 2023-04-11 | Ianchulev Tsontcho | Sale | 40,000 | 4.00 | 160,000 |
| 2023-03-31 | Ianchulev Tsontcho | Sale | 40,000 | 3.50 | 140,000 |
| 2022-12-30 | Grant Stuart M. | Buy | 21,753 | 1.50 | 32,629 |
| 2022-12-30 | Rowe Michael M (CHIEF EXECUTIVE OFFICER) | Buy | 10,000 | 1.54 | 15,400 |
| 2022-08-31 | Strahlman Ellen R | Buy | 6,686 | 1.62 | 10,804 |
| 2022-08-30 | Strahlman Ellen R | Buy | 6,744 | 1.60 | 10,803 |
| 2022-08-29 | Strahlman Ellen R | Buy | 7,931 | 1.62 | 12,840 |
| 2022-06-21 | Grant Stuart M. | Buy | 100,000 | 1.65 | 165,000 |
| 2022-05-19 | Lee Kenneth B Jr | Buy | 10,000 | 2.20 | 22,000 |
| 2022-05-18 | Mather Charles E Iv | Buy | 7,000 | 2.03 | 14,231 |
| 2022-05-11 | Grant Stuart M. | Buy | 25,000 | 1.95 | 48,750 |
| 2022-05-10 | Grant Stuart M. | Buy | 50,000 | 1.98 | 99,000 |
| 2022-05-05 | Grant Stuart M. | Buy | 25,926 | 2.26 | 58,592 |
| 2022-05-04 | Grant Stuart M. | Buy | 24,074 | 2.26 | 54,407 |
| 2022-04-22 | Grant Stuart M. | Buy | 20,000 | 2.55 | 51,000 |
| 2022-04-21 | Grant Stuart M. | Buy | 38,800 | 2.59 | 100,492 |
| 2022-03-31 | Mather Charles E Iv | Buy | 4,000 | 3.12 | 12,460 |
| 2022-02-22 | Grant Stuart M. | Buy | 42,000 | 2.75 | 115,500 |
| 2022-02-18 | Grant Stuart M. | Buy | 10,000 | 2.85 | 28,500 |
| 2022-02-07 | Grant Stuart M. | Buy | 36,030 | 2.97 | 107,009 |
| 2021-12-15 | Grant Stuart M. | Buy | 100,000 | 3.45 | 345,000 |
| 2021-11-16 | Grant Stuart M. | Buy | 25,000 | 3.52 | 88,000 |
| 2021-11-15 | Grant Stuart M. | Buy | 75,000 | 3.64 | 272,775 |
| 2021-11-03 | Ianchulev Tsontcho (CHIEF EXECUTIVE OFFICER) | Buy | 30,000 | 4.04 | 121,200 |
| 2021-11-01 | Mather Charles E Iv | Buy | 4,000 | 3.83 | 15,316 |
| 2021-10-29 | Grant Stuart M. | Buy | 15,505 | 3.75 | 58,066 |
| 2021-10-27 | Rowe Michael M (CHIEF OPERATING OFFICER) | Buy | 1,200 | 4.14 | 4,968 |
| 2021-10-26 | Grant Stuart M. | Buy | 100,000 | 4.00 | 400,000 |
| 2021-10-25 | Grant Stuart M. | Buy | 33,806 | 4.00 | 135,224 |
| 2021-09-13 | Rowe Michael M (Chief Operating Officer) | Buy | 1,500 | 4.40 | 6,600 |
| 2021-08-19 | Grant Stuart M. | Buy | 50,000 | 3.97 | 198,600 |
| 2021-08-18 | Grant Stuart M. | Buy | 924 | 3.94 | 3,642 |
| 2021-08-17 | Grant Stuart M. | Buy | 23,419 | 4.00 | 93,676 |
| 2021-06-17 | Clasby Jennifer G (VP, Regulatory and Clinical) | Option Ex | 24,510 | 1.95 | 47,794 |
| 2021-06-15 | Lee Kenneth B Jr (Director) | Buy | 2,000 | 5.41 | 10,812 |
| 2021-06-14 | Lee Kenneth B Jr (Director) | Buy | 2,000 | 5.47 | 10,940 |
| 2021-06-11 | Lee Kenneth B Jr (Director) | Buy | 2,000 | 5.38 | 10,760 |
| 2021-05-27 | Rowe Michael M (Chief Operating Officer) | Buy | 1,400 | 4.71 | 6,594 |
| 2021-04-20 | Grant Stuart M. | Buy | 30,000 | 4.75 | 142,500 |
| 2021-04-19 | Grant Stuart M. | Buy | 30,692 | 4.88 | 149,776 |
| 2021-03-05 | Grant Stuart M. | Buy | 35,000 | 5.50 | 192,500 |
| 2020-11-19 | Gandolfo John P (Chief Financial Officer) | Buy | 4,000 | 3.40 | 13,600 |
| 2020-09-24 | Grant Stuart M. | Buy | 75,000 | 2.99 | 224,250 |
| 2020-09-18 | Clasby Jennifer G (VP, Clinical Operations) | Option Ex | 26,737 | 1.95 | 52,137 |
| 2020-08-20 | Grant Stuart M. | Buy | 451,620 | 2.06 | 929,433 |
| 2020-08-19 | Grant Stuart M. | Buy | 333,000 | 3.60 | 1,198,800 |
| 2020-03-24 | Ianchulev Tsontcho (Chief Executive Officer) | Buy | 82,431 | 2.27 | 187,118 |
| 2020-03-24 | Mario Ernest (Director) | Buy | 82,431 | 2.27 | 187,118 |
| 2020-03-23 | Grant Stuart M. | Buy | 903,240 | 2.06 | 1,858,867 |
| 2019-11-13 | Grant Stuart M. | Buy | 10,000 | 2.65 | 26,500 |
| 2019-11-12 | Grant Stuart M. | Buy | 29,945 | 2.70 | 80,761 |
| 2019-10-31 | Grant Stuart M. | Buy | 6,072 | 2.71 | 16,449 |
| 2019-10-30 | Grant Stuart M. | Buy | 25,000 | 2.85 | 71,350 |
| 2019-10-17 | Grant Stuart M. | Buy | 3,328 | 3.01 | 10,017 |
| 2019-10-16 | Grant Stuart M. | Buy | 15,000 | 3.14 | 47,055 |
| 2019-10-15 | Grant Stuart M. | Buy | 6,720 | 3.25 | 21,806 |
| 2019-10-14 | Grant Stuart M. | Buy | 6,700 | 3.25 | 21,775 |
| 2019-10-02 | Grant Stuart M. | Buy | 5,000 | 3.33 | 16,650 |
| 2019-10-01 | Grant Stuart M. | Buy | 5,000 | 3.44 | 17,200 |
| 2019-09-30 | Grant Stuart M. | Buy | 17,940 | 3.70 | 66,360 |
| 2019-09-30 | Rowe Michael M (Vice President, Commercial) | Buy | 100 | 3.84 | 384 |
| 2019-09-27 | Grant Stuart M. | Buy | 312 | 4.00 | 1,248 |
| 2019-07-11 | Ianchulev Tsontcho (Chief Executive Officer) | Buy | 233,813 | 2.78 | 650,000 |
| 2019-07-11 | Labelle Curt H (Director) | Buy | 17,985 | 2.78 | 49,998 |
| 2019-07-11 | Mario Ernest (Director) | Buy | 35,971 | 2.78 | 99,999 |
| 2019-05-14 | Yoshida Shuhei (Director) | Option Ex | 33,334 | 1.95 | 65,001 |
| 2019-01-02 | Ianchulev Tsontcho (Chief Executive Officer) | Option Ex | 313,686 | 1.48 | 463,314 |
| 2019-01-02 | Labelle Curt H (Director) | Option Ex | 140,000 | 1.24 | 173,600 |
| 2018-09-25 | Rowe Michael M (Vice President of Marketing) | Buy | 600 | 4.27 | 2,561 |
| 2018-09-24 | Rowe Michael M (Vice President of Marketing) | Buy | 200 | 4.09 | 818 |
| 2018-09-10 | Clasby Jennifer G (VP, Clinical Operations) | Option Ex | 28,965 | 1.95 | 56,481 |
| 2018-06-28 | Ianchulev Tsontcho (Chief Executive Officer) | Buy | 6,000 | 6.63 | 39,780 |
| 2018-06-28 | Gandolfo John P (Chief Financial Officer) | Buy | 2,000 | 5.86 | 11,720 |
| 2018-01-29 | Senju Pharmaceutical Co., Ltd. | Buy | 100,000 | 10.00 | 1,000,000 |
| 2018-01-29 | Ianchulev Tsontcho (Chief Executive Officer) | Buy | 10,000 | 10.00 | 100,000 |
| 2018-01-29 | Yoshida Shuhei | Buy | 100,000 | 10.00 | 1,000,000 |
| 2018-01-29 | Labelle Curt H | Buy | 10,000 | 10.00 | 100,000 |
| 2018-01-29 | Mario Ernest (Director) | Buy | 90,000 | 10.00 | 900,000 |
| 2018-01-29 | Eshelman Fredric N | Buy | 335,000 | 10.00 | 3,350,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of EYEN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Eyenovia, Inc. (symbol EYEN, CIK number 1682639) see the Securities and Exchange Commission (SEC) website.